These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 7238279

  • 1. [Value of successive use of aldactone and aldactacine in the management of congestive heart failure involving at the outset hypokalemia with or without cardiac rhythm disorders].
    Koate P, Diouf S, Sylla M, Diop G, Diop SN.
    Dakar Med; 1981; 26(1):1-11. PubMed ID: 7238279
    [No Abstract] [Full Text] [Related]

  • 2. A fixed-dose combination of furosemide and spironolactone in digitalized congestive heart failure patients.
    Yasky J, Ledesma GA, Tutera A, Collia LF.
    Pharmatherapeutica; 1986; 4(8):473-9. PubMed ID: 3714755
    [Abstract] [Full Text] [Related]

  • 3. [Comparison of the therapeutic efficacy of spironolactone and furosemide in patients with severe congestive heart failure].
    Bednarz B, Cybulski J, Chamiec T.
    Pol Merkur Lekarski; 2000 Aug; 9(50):519-21. PubMed ID: 11081314
    [Abstract] [Full Text] [Related]

  • 4. The treatment of non-digitalized congestive heart failure patients with a fixed-dose combination of furosemide and spironolactone.
    Yasky J, Ledesma GA, Tutera A, Collia LF.
    Pharmatherapeutica; 1986 Aug; 4(8):480-5. PubMed ID: 3714756
    [Abstract] [Full Text] [Related]

  • 5. [Long-term domiciliary oxygen therapy of cardiac failure and cardiac arrhythmia accompanying respiratory insufficiency (author's transl)].
    Daum S, Goerg R, Schlehe H, Wang D.
    Prax Klin Pneumol; 1981 Nov; 35(11):532-7. PubMed ID: 6808483
    [No Abstract] [Full Text] [Related]

  • 6. Spironolactone reduced arrhythmia and maintained magnesium homeostasis in patients with congestive heart failure.
    Gao X, Peng L, Adhikari CM, Lin J, Zuo Z.
    J Card Fail; 2007 Apr; 13(3):170-7. PubMed ID: 17448413
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of a spironolactone and althiazide combination (aldactacine) in Africans with benign essential hypertension.
    Pinto JM.
    East Afr Med J; 1981 Jan; 58(1):44-50. PubMed ID: 7011783
    [No Abstract] [Full Text] [Related]

  • 8. [Hypokalemias and their myocardial disorders].
    Gardere J.
    Poumon Coeur; 1971 Jan; 27(6):587-613. PubMed ID: 5138117
    [No Abstract] [Full Text] [Related]

  • 9. [Clinical test of a diuretic preparation combining a spironoloctone and a sulfonamide derivative].
    Casanova P, Delboy C.
    Mars Med; 1965 Jan; 102(6):551-8. PubMed ID: 5320169
    [No Abstract] [Full Text] [Related]

  • 10. [Direct positive inotropic cardiac effect of aldactone (spironolactone, canrenoate-K)].
    Schröder R, Ramdohr B, Hüttemann U, Schüren KP.
    Dtsch Med Wochenschr; 1972 Oct 13; 97(41):1535-8. PubMed ID: 4561711
    [No Abstract] [Full Text] [Related]

  • 11. Transcardiac gradient of aldosterone before and after spironolactone in patients with congestive heart failure.
    Tsutamoto T, Wada A, Maeda K, Hayashi M, Tsutsui T, Ohnishi M, Fujii M, Matsumoto T, Yamamoto T, Takayama T, Ishii C.
    J Cardiovasc Pharmacol; 2003 Jan 13; 41 Suppl 1():S19-22. PubMed ID: 12688391
    [Abstract] [Full Text] [Related]

  • 12. [Intolerance to spironolactone in refractory cardiac insufficiency. Probable changes in the aldosterone receptors. Study of 11 cases].
    Sänchez Torres G, Posadas C, Boyer JL, Guzmán Lara J, Serrano P.
    Arch Inst Cardiol Mex; 1981 Jan 13; 51(3):233-40. PubMed ID: 6456707
    [No Abstract] [Full Text] [Related]

  • 13. [Effects of spironolactone on myocardial hyperexcitability in decompensated heart failure].
    Tourniaire A, Blum J.
    Coeur Med Interne; 1973 Jan 13; 12(1):147-52. PubMed ID: 4727375
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Spironolactone use in patients with heart failure.
    Trujillo JM, Gonyeau MJ, DiVall MV, Alexander SL.
    J Clin Pharm Ther; 2004 Apr 13; 29(2):165-70. PubMed ID: 15068406
    [Abstract] [Full Text] [Related]

  • 16. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M, Takada M, Hirooka K, Isobe F, Yasumura Y.
    J Clin Pharm Ther; 2005 Dec 13; 30(6):603-10. PubMed ID: 16336294
    [Abstract] [Full Text] [Related]

  • 17. Fracture risk in men with congestive heart failure risk reduction with spironolactone.
    Carbone LD, Cross JD, Raza SH, Bush AJ, Sepanski RJ, Dhawan S, Khan BQ, Gupta M, Ahmad K, Khouzam RN, Dishmon DA, Nesheiwat JP, Hajjar MA, Chishti WA, Nasser W, Khan M, Womack CR, Cho T, Haskin AR, Weber KT.
    J Am Coll Cardiol; 2008 Jul 08; 52(2):135-8. PubMed ID: 18598893
    [Abstract] [Full Text] [Related]

  • 18. The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure.
    Shah KB, Rao K, Sawyer R, Gottlieb SS.
    J Am Coll Cardiol; 2005 Sep 06; 46(5):845-9. PubMed ID: 16139135
    [Abstract] [Full Text] [Related]

  • 19. [Experiences with aldactone in pediatric cardiology (author's transl)].
    Wimmer M, Bachl G, Schlemmer M, Stiskal A.
    Padiatr Padol; 1979 Sep 06; 14(4):363-72. PubMed ID: 530724
    [Abstract] [Full Text] [Related]

  • 20. Paroxysmal atrial fibrillation with asystole and syncope: report of a case of sinus node dysfunction with hypokalemia and hypertension.
    Ohmae M, Nohara Y, Takayasu M, Saimyoji H, Seriu Y.
    Jpn Circ J; 1976 Feb 06; 40(2):127-32. PubMed ID: 768546
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.